![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 13, 2024 7:14:32 PM
Cash increased $367K, not around $1.2M, with $700K of Accounts Receivable appearing to have only been renamed "Receivable from related party", versus actual receipt of back licensing payments ($1.2M payment receipt reported on X on 2/1/24).
Revenue, like all of 2023, appears to reflect 10 state licensing agreements, deviating from reported state agreement counts, with latest being 14 states (as reported in 10/24/23 PR). This should not be related to Dr's over-the-top, personal bonus, contract revenue provision, whereas the total revenue would still be reflected ($210K) partially offset by expense ($63K) for the bonus provision.
Trickle of online sales continues.
Convertible notes remains $323K.
At least a quarterly was on time for the first time in over a year, and Cash increased $350K+.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM